Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...

Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence challenges may be ...

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

Experts have reported promising results from a South African HIV cure trial led by Professor Thumbi Ndung’u of the University of KwaZulu-Natal. The trial shows that 20% of participants remain off ART ...

Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...

When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Rising infections highlight gaps in prevention efforts as experts urge expanded outreach and awareness campaigns ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

THE Tanzania Commission for AIDS (TACAIDS) has urged mining companies in Kahama District, Shinyanga Region, to introduce male ...